After a relatively strong first halfof its fiscal year, Cantel Medical (NYSE: CMD)slowed down a little in its third fiscal quarter. And things don't look like they're going to pick up anytime soon with the medical device maker lowering revenue guidance for the fiscal year, causing shares to drop 16% yesterday.
Cantel Medical Takes Its Foot off the Gas
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться